Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins

References

1. Adachi T., Sagara H., Hirose K., Watanabe H. 2005; Fluoroquinolone resistant Salmonella enterica serovar Paratyphi A. Emerg Infect Dis 11:172–174 [CrossRef]
   [Google Scholar]
2. Capoor M. R., Nair D., Hasan A. S., Aggarwal P., Gupta B. 2006; Narrowing therapeutic options in typhoid fever, India. Southeast Asian J Trop Med Public Health 37:1170–1174
   [Google Scholar]
3. CLSI 2006; Performance Standards for Antimicrobial Susceptibility Testing , 16th Informational Supplement. vol 26 CLSI Document M100–S16 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
4. Cooke F. J., Wain J., Threlfall E. J. 2006; Fluoroquinolone resistance in Salmonella Typhi. BMJ 333:353–354
   [Google Scholar]
5. Gautam V., Gupta N. K., Chaudhary U., Arora D. R. 2002; Sensitivity pattern of salmonella serotypes in Northern India. Braz J Infect Dis 6:281–287
   [Google Scholar]
6. Joshi S., Amarnath S. K. 2006; Fluoroquinolone resistance in Salmonella Typhi and S. Paratyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 101:308–310
   [Google Scholar]
7. Kownhar H., Shankar E. M., Rajan R., Rao G. A. 2007; Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 56:136–137 [CrossRef]
   [Google Scholar]
8. Mandal S., Mandal M. D., Pal N. K. 2004; Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 58:16–23
   [Google Scholar]
9. Marano N., Stamey K., Jarrett B. T., Bopp C., Dabney P., Angulo F. J. the NARMS Working Group 1999; Emerging quinolone and extended spectrum cephalosporin resistant salmonella in the United States. In Proceedings of the 99th General Meeting of the American Society for Microbiology Chicago, IL, USA. Washington, DC: American Society for Microbiology;
   [Google Scholar]
10. Mohanty S., Renuka K., Sood S., Das B. K., Kapil A. 2006; Antibiogram pattern and seasonality of Salmonella in a North Indian tertiary care hospital. Epidemiol Infect 134:961–966 [CrossRef]
    [Google Scholar]
11. Nair S., Unnikrishnan M., Turner K., Parija S. C., Churcher C., Wain J., Harish B. N. 2006; Molecular analysis of fluoroquinolone resistance Salmonella enterica serovar Paratyphi A isolate, India. Emerg Infect Dis 12:489–491 [CrossRef]
    [Google Scholar]
12. Renuka K., Sood S., Das B. K., Kapil A. 2005; High-level ciprofloxacin resistance in Salmonella enterica serovar Typhi in India. J Med Microbiol 54:999–1000 [CrossRef]
    [Google Scholar]
13. Saha S. K., Talukder S. Y., Islam M., Saha S. 1999; A highly ceftriaxone resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J 18:387 [CrossRef]
    [Google Scholar]
14. Saha S. K., Darmstadt G. L., Baqui A. H., Crook D. W., Islam M. N., Islam M., Hossain M., Arifeen S. E., Santoshan M., Black R. E. 2006; Molecular basis of resistance displayed by highly ciprofloxacin resistant Salmonella enterica serovar Typhi in Bangladesh. J Clin Microbiol 44:3811–3813 [CrossRef]
    [Google Scholar]
15. Threlfall E. J., Ward L. R. 2001; Decreased susceptibility to ciprofloxacin in Salmonella enterica serovar Typhi, United Kingdom. Emerg Infect Dis 7:448–450 [CrossRef]
    [Google Scholar]